On November 12, 2025, the President signed into law the Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026. This new […]

Image By: Marty Makary, M.D., M.P.H., Commissioner of Food and Drugs 2026 is a special year for the U.S. Food and Drug Administration. It marks our […]

On January 27, 2026, the Food and Drug Administration approved daratumumab and hyaluronidase-fihj (Darzalex Faspro, Janssen Biotech, Inc.) in combination with bortezomib, lenalidomide, and dexamethasone (VRd) […]

Delivery Method: VIA UNITED PARCEL SERVICE AND VIA E-MAIL Reference #: 26-HFD-45-01-02 Product: Drugs Recipient: Recipient Name Bruce S. Gillis, M.D., MPH Recipient Title CEO Center […]

Delivery Method: Via Email Reference #: 320-26-37 Product: Drugs Over-the-Counter Drugs Recipient: Recipient Name Mr. Soo Nam Tan Recipient Title Group Executive Chairman Fulijaya Manufacturing SDN. […]

On This Page Date: June 2 – 4, 2026 Time: 8:30 a.m. – 5:15 p.m. ET Location: Event Location Library and Archives Canada, Ottawa and Virtual […]

              Online Advisory Letter Reference # 716717   December 4, 2025                         Bodynplant 96 Mowat AveToronto, ON M6K 3M1, CA  RE: Vaginal-Uterine […]

Image CaptionMiracle cure! Truly amazing! Works in minutes! Guaranteed! These are just a few of the false claims made by fraudulent health care products that should […]

Clinical Outcome Assessments (COAs) and Available FDA Pathways to Seek Advice: Additional Considerations: CLINICAL OUTCOME ASSESSMENTS (COAs) AND AVAILABLE FDA PATHWAYS: What is a COA and […]